Peripheral Artery Disease Market Size, Share & Industry Analysis, By Services (Endovascular Devices, Surgical Devices), By Anatomical Site (Aortoiliac, Femoropopliteal), By End-use, By Region and Regional Forecast, 2026-2034

The global peripheral artery disease market size was valued at USD 7.78 billion in 2025. The market is projected to grow from USD 8.19 billion in 2026 to USD 12.35 billion by 2034, exhibiting a CAGR of 5.27% during the forecast period.

The peripheral artery disease market is expanding steadily due to the increasing prevalence of cardiovascular disorders, diabetes, obesity, and aging populations worldwide. Peripheral artery disease affects blood circulation in the lower extremities and is becoming a major public health concern across developed and developing healthcare systems. The peripheral artery disease market Report highlights growing adoption of minimally invasive treatment procedures, advanced vascular imaging systems, and next-generation endovascular devices. Hospitals and specialty vascular clinics are increasingly investing in early diagnosis technologies and catheter-based interventions to improve patient outcomes. Rising awareness regarding limb preservation therapies and preventive cardiovascular care continues supporting peripheral artery disease market Growth globally.

The USA peripheral artery disease market is witnessing strong demand due to increasing incidence of diabetes, smoking-related vascular complications, and sedentary lifestyles. Healthcare providers across the country are prioritizing early diagnosis and minimally invasive revascularization procedures to reduce risks associated with critical limb ischemia and amputations. The USA market is also benefiting from technological advancements in angioplasty balloons, atherectomy systems, and drug-coated stents. Large hospital networks and cardiovascular specialty centers are expanding peripheral vascular treatment programs to address growing patient volumes. The Peripheral Artery Disease Industry Analysis further indicates rising adoption of outpatient vascular interventions throughout the United States healthcare ecosystem.

Key Takeaways

Market Size & Growth

• Global market size 2025: USD 7.78 billion
• Global market size 2034: USD 12.35 billion
• CAGR (2025–2034): 5.27% 

Market Share – Regionals

• North America: 39% 
• Europe: 27%
• Asia-Pacific: 25% 
• Rest of World: 9%

Country-Level Shares

• Germany: 31% of Europe’s market
• United Kingdom: 23% of Europe’s market
• Japan: 24% of Asia-Pacific market 
• China: 41% of Asia-Pacific market

peripheral artery disease market Latest Trends

The peripheral artery disease market Trends are increasingly shaped by the growing adoption of minimally invasive vascular procedures and advanced endovascular technologies. Healthcare providers are shifting from traditional surgical bypass approaches toward catheter-based interventions such as drug-coated balloons, bioresorbable stents, and atherectomy devices that reduce recovery time and improve procedural outcomes. The peripheral artery disease market Analysis highlights rising utilization of image-guided vascular interventions supported by artificial intelligence-assisted diagnostic tools and real-time imaging systems.

Download Free sample to learn more about this report.

Another major trend influencing the peripheral artery disease market Outlook is the increasing focus on early disease screening and preventive cardiovascular healthcare. Hospitals and vascular clinics are expanding ankle-brachial index testing and non-invasive vascular imaging programs to improve early diagnosis rates among high-risk populations. Digital health monitoring systems and wearable vascular assessment technologies are also emerging within chronic disease management programs. The peripheral artery disease market Research Report further indicates strong demand for outpatient vascular treatment services and integrated multidisciplinary care models aimed at improving patient recovery and reducing hospitalization duration.

peripheral artery disease market Dynamics

DRIVER

Rising Prevalence of Diabetes and Cardiovascular Disorders

The primary driver accelerating the peripheral artery disease market Growth is the increasing global prevalence of diabetes, hypertension, obesity, and cardiovascular diseases. These chronic conditions significantly increase the risk of arterial blockage and impaired blood circulation in lower extremities, creating strong demand for vascular diagnosis and treatment solutions. Aging populations are also contributing to rising patient volumes requiring peripheral artery disease management and revascularization procedures.

The peripheral artery disease market Insights indicate that more than 65% of peripheral artery disease patients globally are affected by diabetes or related metabolic disorders. Healthcare systems are prioritizing early intervention and minimally invasive vascular treatments to reduce complications such as limb ischemia and tissue necrosis. Hospitals and specialty cardiovascular centers are increasingly investing in advanced endovascular devices and vascular imaging technologies to improve procedural efficiency and patient outcomes. Growing awareness regarding preventive cardiovascular screening and chronic disease management continues supporting long-term expansion of the Peripheral Artery Disease Industry Report landscape.

RESTRAINT

High Treatment Costs and Limited Access to Specialized Care

One of the major restraints affecting the peripheral artery disease market is the high cost associated with advanced vascular procedures and endovascular treatment devices. Drug-coated balloons, atherectomy systems, vascular stents, and imaging-guided intervention technologies often require substantial healthcare expenditure, limiting accessibility in cost-sensitive healthcare systems. Many developing countries continue facing infrastructure limitations and shortages of trained vascular specialists capable of performing complex peripheral interventions.

The peripheral artery disease market Forecast also highlights reimbursement-related challenges and inconsistent insurance coverage policies affecting patient access to specialized vascular procedures. Approximately 41% of patients in emerging healthcare markets delay treatment because of financial concerns and limited availability of advanced vascular treatment centers. Post-procedural complications and repeat intervention requirements can further increase overall treatment burden. These financial and infrastructure barriers continue impacting broader adoption of advanced peripheral artery disease therapies across several international healthcare markets.

OPPORTUNITY

Expansion of Minimally Invasive Vascular Interventions

The growing demand for minimally invasive treatment procedures presents significant opportunities for the peripheral artery disease market Opportunities segment. Healthcare providers are increasingly preferring catheter-based interventions because they reduce surgical trauma, shorten hospital stays, and improve recovery outcomes compared to traditional open vascular surgery. This trend is creating strong demand for innovative endovascular devices, drug-eluting technologies, and vascular imaging systems.

The peripheral artery disease market Research Report indicates that nearly 58% of newly diagnosed peripheral artery disease patients now undergo minimally invasive procedures as part of vascular treatment programs. Manufacturers investing in next-generation stent technologies, atherectomy devices, and bioresorbable vascular scaffolds are expected to gain substantial competitive advantages. Rising investments in outpatient vascular clinics and ambulatory surgical centers are also expanding procedural accessibility globally. Increasing adoption of robotic-assisted vascular interventions and artificial intelligence-based vascular imaging systems continues strengthening innovation opportunities throughout the Peripheral Artery Disease Industry Analysis.

CHALLENGE

Complex disease diagnosis and recurrence risks

A major challenge within the peripheral artery disease market is the complexity associated with early diagnosis and long-term disease management. Peripheral artery disease symptoms often remain undetected during initial stages, resulting in delayed treatment and increased risk of severe complications such as critical limb ischemia. Many patients are diagnosed only after experiencing advanced vascular obstruction or chronic wound formation, making treatment more complicated and resource-intensive.

The peripheral artery disease market Report further indicates that recurrence rates following endovascular interventions remain a significant clinical concern. Nearly 36% of patients undergoing peripheral vascular procedures require additional follow-up treatments because of restenosis or progressive arterial blockage. Healthcare providers also face operational challenges related to multidisciplinary coordination between cardiologists, vascular surgeons, radiologists, and rehabilitation specialists. In addition, differences in healthcare infrastructure quality and specialist availability across regions continue affecting patient outcomes. These factors remain critical operational and clinical challenges across the global peripheral artery disease market Outlook.

peripheral artery disease market Segmentation

By Services

Endovascular devices represent the dominant segment within the peripheral artery disease market due to the increasing preference for minimally invasive vascular interventions. This category includes angioplasty balloons, stents, atherectomy systems, thrombectomy devices, and drug-coated vascular technologies designed to restore arterial blood flow with minimal surgical trauma. Endovascular devices account for approximately 63% of the global peripheral artery disease market Share because of rising procedural volumes in hospitals and outpatient vascular centers. The peripheral artery disease market Trends indicate strong demand for drug-eluting balloons and bioresorbable vascular scaffolds capable of reducing restenosis rates and improving long-term patient outcomes. Healthcare providers are increasingly adopting image-guided catheter technologies and precision vascular intervention systems to improve procedural accuracy. Manufacturers are focusing heavily on flexible stent designs, low-profile catheter systems, and enhanced drug-delivery mechanisms to strengthen product differentiation. Growing adoption of outpatient vascular procedures and reduced hospitalization requirements continue driving strong growth within the endovascular devices segment globally.

Surgical devices continue playing an essential role within the peripheral artery disease market Size, particularly in severe arterial blockage cases requiring bypass grafting or advanced vascular reconstruction procedures. This segment contributes nearly 37% of the total market share and includes vascular grafts, surgical instruments, bypass systems, and thrombectomy equipment used in open surgical interventions. Surgical procedures remain critical for patients experiencing extensive vascular occlusion or failed endovascular treatments. The peripheral artery disease market Analysis highlights increasing demand for advanced biocompatible graft materials and precision surgical instruments designed to improve long-term vascular repair outcomes. Hospitals and cardiovascular specialty centers are increasingly integrating hybrid operating rooms that combine surgical and endovascular capabilities to support complex vascular procedures. Manufacturers are investing in improved graft durability, infection-resistant materials, and minimally invasive surgical support technologies to enhance patient recovery. Rising prevalence of advanced-stage peripheral artery disease continues sustaining procedural demand within this segment despite growing preference for catheter-based therapies.

By Anatomical Site

The aortoiliac segment represents a significant category within the peripheral artery disease market because of increasing diagnosis rates associated with arterial narrowing in the abdominal and pelvic vascular regions. This segment accounts for approximately 34% of the global peripheral artery disease market Share due to growing demand for advanced stenting procedures and vascular reconstruction therapies. Aortoiliac disease management often requires highly specialized imaging systems and catheter-based interventions to restore blood circulation effectively. The peripheral artery disease market Research Report highlights rising adoption of covered stents, balloon-expandable devices, and advanced imaging-guided therapies for treating complex aortoiliac lesions. Healthcare providers are increasingly focusing on minimally invasive treatment approaches that reduce surgical complications and improve mobility recovery among elderly patients. Expansion of vascular specialty clinics and increasing physician expertise in complex peripheral interventions continue supporting growth within the aortoiliac treatment segment globally.

The femoropopliteal segment dominates the peripheral artery disease market Outlook because femoral and popliteal arteries are among the most frequently affected vascular regions in peripheral artery disease patients. This segment contributes approximately 66% of market demand driven by high prevalence of lower-limb arterial blockage associated with diabetes, smoking, and aging-related vascular degeneration. Drug-coated balloons, self-expanding stents, and atherectomy devices are widely utilized within femoropopliteal interventions. The Peripheral Artery Disease Industry Report indicates increasing procedural demand for long-lesion treatment technologies and advanced vascular imaging systems capable of improving procedural precision. Healthcare providers are prioritizing limb preservation therapies and minimally invasive revascularization approaches to reduce amputation risks among high-risk patients. Manufacturers are focusing on improved stent flexibility, fracture resistance, and drug-delivery performance to strengthen therapeutic effectiveness within femoropopliteal interventions. Rising prevalence of chronic limb ischemia continues supporting strong procedural growth across this segment.

By End-use

Hospitals remain the largest end-use segment within the peripheral artery disease market because they provide comprehensive vascular diagnosis, intervention, surgical treatment, and rehabilitation services. This segment accounts for approximately 54% of global market demand supported by increasing patient admissions related to advanced cardiovascular complications. Large hospitals are investing heavily in hybrid operating rooms, advanced vascular imaging systems, and multidisciplinary cardiovascular treatment programs. The peripheral artery disease market Forecast indicates growing adoption of robotic-assisted vascular procedures and minimally invasive intervention suites across tertiary healthcare institutions. Hospitals are also expanding specialized peripheral vascular clinics to improve early disease detection and treatment accessibility. Increasing healthcare investments in advanced vascular infrastructure and skilled interventional specialists continue strengthening hospital dominance within the peripheral artery disease treatment ecosystem.

Ambulatory surgical centers and specialty vascular clinics are emerging rapidly within the peripheral artery disease market Opportunities landscape due to growing demand for outpatient vascular interventions and shorter recovery times. This segment contributes approximately 46% of the global market share because minimally invasive procedures can often be performed without prolonged hospitalization. Outpatient centers are increasingly adopting catheter-based vascular technologies and advanced imaging systems to support efficient peripheral interventions. The peripheral artery disease market Insights reveal rising patient preference for cost-effective outpatient treatment environments offering faster discharge and reduced procedural waiting periods. Specialty vascular clinics are expanding integrated care services involving vascular imaging, wound management, and rehabilitation support. Manufacturers are increasingly targeting ambulatory care providers with compact imaging systems, portable vascular intervention devices, and simplified procedural technologies. Expansion of outpatient healthcare infrastructure continues driving strong long-term growth opportunities across this segment globally.

peripheral artery disease market Regional Outlook

North America

North America remains the leading regional contributor to the peripheral artery disease market due to advanced healthcare infrastructure, high cardiovascular disease prevalence, and strong adoption of minimally invasive vascular technologies. The region accounts for approximately 39% of global market share supported by increasing patient awareness and extensive availability of specialized vascular treatment centers. Hospitals and cardiovascular clinics across the United States and Canada are heavily investing in advanced endovascular systems and hybrid vascular operating rooms.

The peripheral artery disease market Outlook in North America is also strengthened by rising healthcare expenditure and widespread adoption of outpatient vascular interventions. Healthcare providers are increasingly focusing on limb preservation therapies and early vascular disease screening programs to reduce amputation risks. Technological innovation involving drug-coated balloons, atherectomy systems, and imaging-guided vascular interventions continues driving regional market expansion. Strong clinical research activity and physician expertise further support North America’s leadership position within the peripheral artery disease industry.

Europe

Europe continues demonstrating significant growth within the peripheral artery disease market because of increasing elderly populations and strong cardiovascular disease management programs. The region contributes nearly 27% of global market share driven by rising adoption of minimally invasive vascular interventions and expanding healthcare modernization initiatives. European healthcare systems are prioritizing preventive vascular screening and integrated cardiovascular care models aimed at improving patient outcomes.

The peripheral artery disease market Analysis indicates increasing investments in advanced imaging systems, vascular specialty centers, and hybrid operating facilities throughout Europe. Hospitals are increasingly adopting bioresorbable vascular technologies and image-guided interventions to enhance procedural efficiency. Regulatory emphasis on chronic disease prevention and improved rehabilitation services continues strengthening market demand. Expansion of outpatient vascular treatment programs and physician training initiatives also supports continued growth within the European peripheral artery disease market.

Germany peripheral artery disease market

Germany represents one of the most advanced markets within the European peripheral artery disease market ecosystem because of its strong healthcare infrastructure and high adoption of vascular intervention technologies. The country contributes approximately 31% of Europe’s regional market supported by increasing diagnosis rates of diabetes-related vascular disorders and strong demand for minimally invasive treatment procedures. German hospitals and cardiovascular centers are investing heavily in hybrid vascular operating rooms and advanced imaging-guided intervention systems.

The peripheral artery disease market Research Report highlights growing adoption of drug-coated balloons, atherectomy devices, and precision stent technologies throughout Germany. Healthcare providers are focusing on improving early diagnosis rates and reducing complications associated with critical limb ischemia. Expansion of specialized vascular rehabilitation programs and multidisciplinary cardiovascular treatment models continues strengthening long-term market growth. Germany’s strong clinical research environment and advanced reimbursement structure further support technological innovation across the domestic peripheral artery disease market.

United Kingdom peripheral artery disease market

The United Kingdom peripheral artery disease market is expanding steadily due to rising awareness regarding cardiovascular health and increasing prevalence of diabetes-related vascular complications. The country accounts for approximately 23% of Europe’s regional market supported by growing investments in minimally invasive vascular treatment infrastructure and outpatient cardiovascular care services. Healthcare providers across the United Kingdom are prioritizing early screening programs and integrated chronic disease management strategies.

The Peripheral Artery Disease Industry Analysis indicates increasing demand for image-guided endovascular procedures and advanced vascular imaging systems throughout the United Kingdom healthcare ecosystem. Hospitals and specialty vascular clinics are adopting drug-coated technologies and precision catheter systems to improve procedural outcomes and reduce hospitalization periods. Rising focus on patient rehabilitation, limb preservation therapies, and preventive cardiovascular care continues supporting long-term growth opportunities across the United Kingdom peripheral artery disease market.

Asia-Pacific

Asia-Pacific is emerging as one of the fastest-growing regions within the peripheral artery disease market Forecast due to increasing cardiovascular disease prevalence, urbanization, and healthcare infrastructure expansion. The region accounts for approximately 25% of global market share supported by rising diagnosis rates of diabetes and peripheral vascular disorders across China, Japan, India, and South Korea. Healthcare providers are increasingly adopting minimally invasive vascular interventions and advanced diagnostic imaging technologies.

The peripheral artery disease market Growth across Asia-Pacific is being accelerated by government healthcare modernization initiatives and rising investments in cardiovascular specialty centers. Expansion of private healthcare networks and increasing physician expertise in vascular interventions continue improving treatment accessibility. Manufacturers are also introducing cost-effective vascular devices tailored for high-volume healthcare systems across emerging economies. Rising public awareness regarding chronic disease prevention and early vascular screening programs further supports long-term regional market expansion.

Japan peripheral artery disease market

Japan represents a technologically advanced segment within the Asia-Pacific peripheral artery disease market because of its aging population and strong healthcare innovation capabilities. The country contributes approximately 24% of regional market demand driven by increasing prevalence of diabetes, hypertension, and age-related vascular disorders. Japanese healthcare providers are actively investing in minimally invasive vascular technologies and precision imaging systems aimed at improving patient outcomes and reducing surgical complications.

The peripheral artery disease market Trends in Japan indicate rising demand for bioresorbable vascular scaffolds, drug-coated devices, and robotic-assisted vascular interventions. Hospitals and cardiovascular centers are focusing heavily on preventive screening programs and integrated rehabilitation services to improve long-term disease management. Manufacturers are also developing compact catheter systems and advanced imaging-guided technologies aligned with Japan’s highly sophisticated healthcare environment. Increasing healthcare investments and strong physician expertise continue supporting market expansion across the Japanese peripheral artery disease treatment landscape.

China peripheral artery disease market

China remains one of the largest growth markets within the Asia-Pacific peripheral artery disease market Size because of rapid urbanization, rising diabetes prevalence, and expanding healthcare infrastructure. The country accounts for approximately 41% of regional market demand supported by increasing investments in cardiovascular specialty hospitals and vascular intervention programs. Chinese healthcare providers are increasingly adopting minimally invasive treatment procedures and advanced vascular imaging technologies to improve patient outcomes.

The peripheral artery disease market Opportunities in China are expanding rapidly due to growing healthcare accessibility and increasing public awareness regarding chronic cardiovascular diseases. Domestic manufacturers are introducing affordable vascular intervention devices and imaging systems targeted at large-scale hospital networks. Government healthcare reforms and rising investments in advanced cardiovascular treatment infrastructure continue supporting strong market development. Expansion of outpatient vascular clinics and physician training programs is also strengthening long-term procedural demand across China’s peripheral artery disease market ecosystem.

Rest of World

The Rest of World region, including Latin America, the Middle East, and Africa, continues contributing steadily to the peripheral artery disease market Outlook because of increasing cardiovascular disease burden and improving healthcare infrastructure. The region contributes approximately 9% of global market share supported by growing investments in vascular treatment centers and diagnostic imaging systems. Rising awareness regarding diabetes-related vascular complications is encouraging healthcare providers to expand peripheral artery disease screening and intervention programs.

The peripheral artery disease market Report highlights increasing adoption of cost-effective endovascular technologies and outpatient vascular procedures across emerging healthcare systems. Hospitals and specialty clinics are increasingly investing in minimally invasive treatment capabilities to improve patient accessibility and reduce procedural costs. Government healthcare modernization initiatives and rising chronic disease management programs continue supporting market growth opportunities throughout Latin America, the Middle East, and Africa.

List of Top Peripheral Artery Disease Companies

• BD
• Bentley InnoMed
• Scitech Medical
• Abbott Laboratories
• Boston Scientific Corporation
• W. L. Gore & Associates, Inc.
• Medtronic
• Cook
• Terumo Corporation
• iVascular
• Getinge AB
• Biotronik SE & Co KG

Top Two Companies by Market Share

• Medtronic – 19%
• Boston Scientific Corporation – 16%

Investment Analysis and Opportunities

The peripheral artery disease market is attracting strong investment due to rising cardiovascular disease prevalence and increasing demand for minimally invasive vascular procedures. Medical device manufacturers, hospital networks, and healthcare investors are expanding funding toward advanced endovascular technologies, vascular imaging systems, and outpatient intervention infrastructure. Growing demand for drug-coated balloons, precision stents, and atherectomy systems continues strengthening investment activity across global vascular healthcare markets.

The peripheral artery disease market Opportunities are especially prominent in outpatient vascular centers and emerging healthcare economies where access to minimally invasive procedures is improving rapidly. Approximately 57% of healthcare institutions investing in vascular care modernization now prioritize advanced catheter-based intervention technologies and image-guided treatment systems. Investors are increasingly supporting robotic-assisted vascular surgery, artificial intelligence-based imaging platforms, and next-generation bioresorbable vascular devices. Expansion of physician training programs, telemedicine-enabled vascular screening initiatives, and integrated rehabilitation services continues generating substantial growth opportunities throughout the Peripheral Artery Disease Industry Report landscape.

New Product Development

New product development within the peripheral artery disease market is increasingly focused on improving procedural precision, reducing restenosis risks, and enhancing patient recovery outcomes. Manufacturers are introducing next-generation drug-coated balloons, bioresorbable stents, and low-profile catheter systems designed to improve blood flow restoration and minimize repeat interventions. Product innovation is also centered around enhanced imaging-guided vascular navigation technologies and flexible stent structures suitable for complex arterial anatomies.

The peripheral artery disease market Trends indicate growing interest in artificial intelligence-supported vascular imaging systems capable of improving lesion identification and procedural planning. Companies are also developing robotic-assisted vascular intervention platforms aimed at improving treatment accuracy and reducing physician fatigue during complex procedures. Advanced atherectomy systems featuring improved plaque removal capabilities and reduced vascular trauma are becoming increasingly important within the peripheral intervention landscape. Continuous innovation in minimally invasive vascular technologies continues strengthening competition throughout the global peripheral artery disease industry.

Five Recent Developments (2023-2025)

• Medtronic introduced advanced drug-coated balloon technologies for femoropopliteal interventions in 2024.
• Boston Scientific Corporation expanded its peripheral vascular portfolio with next-generation atherectomy systems in 2025.
• Abbott Laboratories launched enhanced imaging-guided vascular intervention platforms for peripheral artery disease treatment in 2023.
• Terumo Corporation developed low-profile vascular stent delivery systems designed for complex arterial anatomies in 2024.
• BD expanded production capacity for minimally invasive peripheral intervention devices to support rising procedural demand in 2025.

Report Coverage of peripheral artery disease market

The peripheral artery disease market Report provides comprehensive analysis of vascular intervention technologies, disease management strategies, competitive market dynamics, and treatment adoption trends shaping the global peripheral artery disease industry. The report evaluates diagnostic technologies, minimally invasive procedures, surgical treatment approaches, and end-use healthcare infrastructure supporting patient care and vascular rehabilitation. Detailed segmentation analysis by device category, anatomical treatment site, and healthcare end-use provides valuable business insights for manufacturers, healthcare providers, and investors.

Request for Customization   to gain extensive market insights.

The peripheral artery disease market Research Report also covers technological advancements involving drug-coated devices, vascular imaging systems, robotic-assisted interventions, and bioresorbable vascular technologies. Regional analysis examines healthcare infrastructure development, physician expertise expansion, chronic disease prevalence, and outpatient procedural growth across major international markets. Competitive benchmarking highlights product innovation strategies, clinical expansion initiatives, and investment trends adopted by leading peripheral artery disease companies. The report further analyzes future opportunities associated with artificial intelligence-based vascular diagnostics, integrated rehabilitation programs, and minimally invasive cardiovascular treatment technologies.